JPWO2022030626A1 - - Google Patents

Info

Publication number
JPWO2022030626A1
JPWO2022030626A1 JP2022541754A JP2022541754A JPWO2022030626A1 JP WO2022030626 A1 JPWO2022030626 A1 JP WO2022030626A1 JP 2022541754 A JP2022541754 A JP 2022541754A JP 2022541754 A JP2022541754 A JP 2022541754A JP WO2022030626 A1 JPWO2022030626 A1 JP WO2022030626A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022541754A
Other languages
Japanese (ja)
Other versions
JP7855199B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022030626A1 publication Critical patent/JPWO2022030626A1/ja
Application granted granted Critical
Publication of JP7855199B2 publication Critical patent/JP7855199B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2022541754A 2020-08-06 2021-08-06 膀胱癌診断方法 Active JP7855199B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020133478 2020-08-06
JP2020133478 2020-08-06
PCT/JP2021/029360 WO2022030626A1 (ja) 2020-08-06 2021-08-06 膀胱癌診断方法

Publications (2)

Publication Number Publication Date
JPWO2022030626A1 true JPWO2022030626A1 (https=) 2022-02-10
JP7855199B2 JP7855199B2 (ja) 2026-05-08

Family

ID=

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016143805A1 (ja) * 2015-03-10 2016-09-15 テオリアサイエンス株式会社 膀胱がんの検出方法
JP2017526916A (ja) * 2014-08-13 2017-09-14 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 癌の診断
US20170350902A1 (en) * 2016-06-06 2017-12-07 China Medical University Method for validating existence of urinary exosome, non-invasive method for identifying urothelial cancer, and method for predicting recurrence and progression of urothelial cancer patient after treatment
JP2018533368A (ja) * 2015-08-31 2018-11-15 日立化成株式会社 尿路上皮疾患の評価のための分子法
US20180372754A1 (en) * 2015-12-23 2018-12-27 Polyquant Gmbh Bladder cancer biomarker proteins
CN109762899A (zh) * 2018-12-28 2019-05-17 广州恒泰生物科技有限公司 一种利用尿液外泌体进行非侵入式检测患膀胱癌的概率的试剂盒
JP2019215342A (ja) * 2018-06-07 2019-12-19 株式会社Ｌｓｉメディエンス ヒト尿からのマイクロベシクルの分離方法及び分析方法
WO2020071489A1 (ja) * 2018-10-04 2020-04-09 国立大学法人大阪大学 尿路上皮がんを検査する方法

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017526916A (ja) * 2014-08-13 2017-09-14 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 癌の診断
WO2016143805A1 (ja) * 2015-03-10 2016-09-15 テオリアサイエンス株式会社 膀胱がんの検出方法
JP2018533368A (ja) * 2015-08-31 2018-11-15 日立化成株式会社 尿路上皮疾患の評価のための分子法
US20180372754A1 (en) * 2015-12-23 2018-12-27 Polyquant Gmbh Bladder cancer biomarker proteins
US20170350902A1 (en) * 2016-06-06 2017-12-07 China Medical University Method for validating existence of urinary exosome, non-invasive method for identifying urothelial cancer, and method for predicting recurrence and progression of urothelial cancer patient after treatment
JP2019215342A (ja) * 2018-06-07 2019-12-19 株式会社Ｌｓｉメディエンス ヒト尿からのマイクロベシクルの分離方法及び分析方法
WO2020071489A1 (ja) * 2018-10-04 2020-04-09 国立大学法人大阪大学 尿路上皮がんを検査する方法
CN109762899A (zh) * 2018-12-28 2019-05-17 广州恒泰生物科技有限公司 一种利用尿液外泌体进行非侵入式检测患膀胱癌的概率的试剂盒

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEN CHIEN-LUN ET AL.: "Comparative and Targeted Proteomic Analyses of Urinary Microparticles from Bladder Cancer and Hernia", JOURNAL OF PROTEOME RESEARCH, vol. 11, JPN6025030999, 19 October 2012 (2012-10-19), pages 5611 - 5629, ISSN: 0005656568 *
DE OLIVEIRA MANUEL CASTANHEIRA ET AL.: "Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles", CANCERS, vol. 12, JPN6021033861, 29 May 2020 (2020-05-29), pages 1400, ISSN: 0005656567 *
LEE JINGYUN ET AL.: "Altered Proteome of Extracellular Vesicles Derived from Bladder Cancer Patients Urine", MOLECULES AND CELLS, vol. 41, no. 3, JPN6021033863, 9 March 2018 (2018-03-09), pages 179 - 187, ISSN: 0005656566 *
SMALLEY DAVID M ET AL.: "Isolation and Identification of Potential Urinary Microparticle Biomarkers of Bladder Cancer", JOURNAL OF PROTEOME RESEARCH, vol. 7, JPN6025031000, 29 March 2008 (2008-03-29), pages 2088 - 2096, ISSN: 0005656569 *

Also Published As

Publication number Publication date
WO2022030626A1 (ja) 2022-02-10
EP4194856A1 (en) 2023-06-14
US20230266323A1 (en) 2023-08-24
EP4194856A4 (en) 2024-12-11

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230208

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251003

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260109

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260317

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260414